Position in ALNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$34,702,435
+$5,050,200 QoQ
Shares Held
115,279
+28.6% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#99
of 780 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Derivatives in ALNY
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$36,304,218
PutShares
120,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026HSBC HOLDINGS PLC holds $1,221,504,678 across 135 Biotechnology names. ALNY ranks #6 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
676,247 | $335,912,169 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
382,028 | $238,209,735 | |
| 3 | INCY |
Incyte Corp
|
1,307,743 | $148,245,744 | |
| 4 | RPRX |
Royalty Pharma plc
|
1,224,925 | $68,681,542 | |
| 5 | MRNA |
Moderna, Inc.
|
636,199 | $44,553,014 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
115,279 | $34,702,435 | |
| 7 | INSM |
INSMED Inc
|
279,961 | $29,849,438 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
307,543 | $17,597,610 |
All Filings in ALNY
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,304,218 | 120,600 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $34,702,435 | 115,279 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $29,652,235 | 89,619 | Shares | Defined | 2026-04-30 | |
| 2026-03-31 | $37,917,702 | 114,600 | Put | Defined | 2026-04-30 | |
| 2025-12-31 | $45,570,690 | 114,600 | Put | Defined | 2026-03-20 | |
| 2025-12-31 | $35,596,432 | 89,517 | Shares | Defined | 2026-03-06 | |
| 2025-09-30 | $33,294,384 | 73,014 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $26,657,203 | 81,748 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $16,542,773 | 61,265 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $14,490,857 | 61,582 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $15,640,952 | 56,870 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $13,159,665 | 54,155 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $11,078,877 | 74,131 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $8,460,129 | 44,199 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $6,231,262 | 35,185 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $5,826,787 | 30,677 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,871,373 | 39,294 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,779,234 | 32,734 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,084,261 | 35,393 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,272,226 | 49,861 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $7,809,669 | 47,827 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $7,010,436 | 41,340 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $5,421,488 | 28,714 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,697,398 | 27,710 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $4,647,973 | 32,920 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $4,352,694 | 33,490 | Shares | Defined | 2021-02-25 | |
| 2020-09-30 | $5,048,679 | 34,675 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,446,925 | 16,521 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,035,054 | 9,509 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||